John Russel Denton insider trades: Caris Life Sciences (CAI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | CAI | ↓ Sell | 7,500 | $31.82 | $239K | Direct | Sep 23, 2026 (1d) |
| Nov 7, 2025 | CAI | ↑ Buy | 4,184 | $24.09 | $101K | By Trust | Nov 10, 2025 (3d) |
| Jun 20, 2025 | CAI | ↑ Buy | 7,500 | $21.00 | $158K | Direct | Jun 23, 2025 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CAI insiders
Open-market trades in the last 12 months
About John Russel Denton's insider trades
John Russel Denton is See Remarks at Caris Life Sciences (CAI). Since Jun 20, 2025, John has reported 2 open-market purchases worth $258K and 1 sale worth $239K on SEC Form 4. In the last 12 months: 1 buy ($101K) and 1 sale ($239K).
Their filings also include grants and awards (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CAI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.